BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30851333)

  • 21. Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors.
    Kim JY; Kim J; Kim YI; Yang DH; Yoo C; Park IJ; Ryoo BY; Ryu JS; Hong SM
    Sci Rep; 2024 Feb; 14(1):4047. PubMed ID: 38374188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-exome sequencing of rectal neuroendocrine tumors.
    Li Y; Guo Y; Cheng Z; Tian C; Chen Y; Chen R; Yu F; Shi Y; Su F; Zhao S; Wang Z; Luo J; Tan H
    Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 36645718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survival.
    Lee HS; Chen M; Kim JH; Kim WH; Ahn S; Maeng K; Allegra CJ; Kaye FJ; Hochwald SN; Zajac-Kaye M
    Int J Cancer; 2014 Jul; 135(1):128-37. PubMed ID: 24347111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroendocrine Tumors of the Appendix, Colon, and Rectum.
    Hrabe J
    Surg Oncol Clin N Am; 2020 Apr; 29(2):267-279. PubMed ID: 32151360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment.
    Pepe F; Pisapia P; Del Basso de Caro ML; Conticelli F; Malapelle U; Troncone G; Martinez JC
    Histol Histopathol; 2020 Jul; 35(7):741-749. PubMed ID: 31872418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower gastrointestinal neuroendocrine neoplasms associated with hereditary cancer syndromes: a case series.
    Kidambi TD; Pedley C; Blanco A; Bergsland EK; Terdiman JP
    Fam Cancer; 2017 Oct; 16(4):537-543. PubMed ID: 28283864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.
    Jernman J; Välimäki MJ; Louhimo J; Haglund C; Arola J
    Neuroendocrinology; 2012; 95(4):317-24. PubMed ID: 22327359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group.
    Vollbrecht C; Werner R; Walter RF; Christoph DC; Heukamp LC; Peifer M; Hirsch B; Burbat L; Mairinger T; Schmid KW; Wohlschlaeger J; Mairinger FD
    Br J Cancer; 2015 Dec; 113(12):1704-11. PubMed ID: 26645239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.
    Vanoli A; La Rosa S; Miceli E; Klersy C; Maragliano R; Capuano F; Persichella A; Martino M; Inzani F; Luinetti O; Di Sabatino A; Sessa F; Paulli M; Corazza GR; Rindi G; Bordi C; Capella C; Solcia E
    Neuroendocrinology; 2018; 107(2):114-126. PubMed ID: 29895024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varying malignant potential of appendiceal neuroendocrine tumors: importance of histologic subtype.
    Hsu C; Rashid A; Xing Y; Chiang YJ; Chagpar RB; Fournier KF; Chang GJ; You YN; Feig BW; Cormier JN
    J Surg Oncol; 2013 Feb; 107(2):136-43. PubMed ID: 22767417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine carcinoma and mixed neuroendocrine‒non-neuroendocrine neoplasm of the stomach: a clinicopathological and exome sequencing study.
    Ishida S; Akita M; Fujikura K; Komatsu M; Sawada R; Matsumoto H; Saegusa J; Itoh T; Kakeji Y; Zen Y
    Hum Pathol; 2021 Apr; 110():1-10. PubMed ID: 33359239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary renal well-differentiated neuroendocrine tumour (carcinoid): next-generation sequencing study of 11 cases.
    Pivovarcikova K; Agaimy A; Martinek P; Alaghehbandan R; Perez-Montiel D; Alvarado-Cabrero I; Rogala J; Kuroda N; Rychly B; Gasparov S; Michalova K; Michal M; Hora M; Pitra T; Tuckova I; Laciok S; Mareckova J; Hes O
    Histopathology; 2019 Jul; 75(1):104-117. PubMed ID: 30851202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colon and Rectal Neuroendocrine Tumors: Are They Really One Disease? A Single-Institution Experience over 15 Years.
    Broecker JS; Ethun CG; Postlewait LM; Le N; McInnis M; Russell MC; Sullivan P; Kooby DA; Staley CA; Maithel SK; Cardona K
    Am Surg; 2018 May; 84(5):717-726. PubMed ID: 29966574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.
    Kwon MJ; Kang HS; Soh JS; Lim H; Kim JH; Park CK; Park HR; Nam ES
    World J Gastroenterol; 2016 Nov; 22(42):9400-9410. PubMed ID: 27895428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation Profile of Thymic Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation Sequencing.
    Sakane T; Sakamoto Y; Masaki A; Murase T; Okuda K; Nakanishi R; Inagaki H
    Clin Lung Cancer; 2021 Mar; 22(2):92-99.e4. PubMed ID: 33414055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological characteristics and frequency of multiple rectal neuroendocrine tumors: a single-center retrospective study.
    Nishikawa Y; Chino A; Ide D; Saito S; Igarashi M; Takamatsu M; Fujisaki J; Igarashi Y
    Int J Colorectal Dis; 2019 Nov; 34(11):1887-1894. PubMed ID: 31630212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-L-cell immunophenotype and large tumor size in rectal neuroendocrine tumors are associated with aggressive clinical behavior and worse prognosis.
    Kim JY; Kim KS; Kim KJ; Park IJ; Lee JL; Myung SJ; Park Y; Park YS; Yu CS; Kim JC; Yu E; Jang HJ; Hong SM
    Am J Surg Pathol; 2015 May; 39(5):632-43. PubMed ID: 25724002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PROX1 is involved in progression of rectal neuroendocrine tumors, NETs.
    Jernman J; Kallio P; Hagström J; Välimäki MJ; Haapasalo H; Alitalo K; Arola J; Haglund C
    Virchows Arch; 2015 Sep; 467(3):279-84. PubMed ID: 26063416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing.
    Nemtsova MV; Kalinkin AI; Kuznetsova EB; Bure IV; Alekseeva EA; Bykov II; Khorobrykh TV; Mikhaylenko DS; Tanas AS; Kutsev SI; Zaletaev DV; Strelnikov VV
    Sci Rep; 2020 Jan; 10(1):504. PubMed ID: 31949278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational analysis by next generation sequencing of gastric type dysplasia occurring in hyperplastic polyps of the stomach: Mutations in gastric hyperplastic polyps.
    Salomao M; Luna AM; Sepulveda JL; Sepulveda AR
    Exp Mol Pathol; 2015 Dec; 99(3):468-73. PubMed ID: 26325218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.